Article
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs
2023-11-08
Abstract excerpt
<title>Abstract</title> <p>The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy. This guideline describes the gene-drug interaction of <italic>CYP2C9</italic> and <italic>HLA-B</italic> with phenytoin, <italic>HLA-A</italic> and <italic>HLA-B</italic> with carbamazepine and <italic>HLA-B</italic>...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b4a899b3-bc20-54d5-8be5-21a3fd1851c5
- DOI
- 10.21203/rs.3.rs-3255043/v1
